SCHEMBL20877661

SCHEMBL20877661

C=CC([C@H](O)C=C)N1C(=O)C(=O)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 10/20 0.41
▸ TTR P02766 1/20 0.41
▸ BCHE P06276 3/20 0.40
▸ TGM2 P21980 1/20 0.40
▸ CASP3 P42574 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ CES2 O00748 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALDH3A1 P30838 2/20 0.36
▸ ALDH2 P05091 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ AGTR1 P30556 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ RCE1 Q9Y256 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20877660 1.00 CES1 (0.41) CES1TTRBCHETGM2CASP3
SCHEMBL20877618 0.82 CASP3 (0.41) CASP3ALDH1A1GAANPSR1
SCHEMBL20877620 0.82 CASP3 (0.41) CASP3ALDH1A1GAANPSR1
SCHEMBL28362284 0.74 CES1 (0.44) CES1TTRBCHETGM2CASP3
SCHEMBL4803383 0.74 CES1 (0.53) CES1TTRBCHETGM2CASP3
SCHEMBL18281472 0.70 CES1 (0.57) CES1TTRBCHETGM2CASP3
SCHEMBL4199767 0.70 CES1 (0.57) CES1TTRBCHETGM2CASP3
SCHEMBL19924174 0.69 CES1 (0.50) CES1TTRBCHETGM2CASP3
Hydrochloric Acid SCHEMBL29591677 0.68 CES1 (0.55) CES1TTRBCHETGM2CASP3
SCHEMBL281336 0.67 CES1 (0.50) CES1TTRBCHETGM2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752625-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds SCIFLUOR LIFE SCIENCES, INC. (US) 2020-08-25 — — US disclosed
US-20190194195-A1 METHOD OF MAKING TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID COMPOUNDS FELIQS CORPORATION (JP) 2019-06-27 — — US disclosed
US-10253025-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds SCIFLUOR LIFE SCIENCES, INC. (US) 2019-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194195-A1 METHOD OF MAKING TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID COMPOUNDS NISCH, SLC10A1, AANAT CES1 382/4885TTR 448/4885BCHE 357/4885
US-10752625-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds NISCH, SLC10A1, AANAT CES1 382/4885TTR 448/4885BCHE 357/4885
US-10253025-B2 Method of making tetrahydronaphthyridinyl nonanoic acid compounds NISCH, SLC10A1, AANAT CES1 382/4885TTR 448/4885BCHE 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback